This site is intended for Healthcare Professionals only.

India’s Reliance Industries explores bid for Walgreens’ Boots business: Bloomberg News

Date:

Share post:

Indian billionaire Mukesh Ambani’s Reliance Industries is exploring a bid for Boots UK, Bloomberg News reported last week, citing people familiar with the matter.

Walgreens Boots Alliance is selling its UK-based Boots business as part of an auction process led by Goldman Sachs and can be valued at up to £8 billion, Reuters reported in February, citing sources.

The Boots business spans across 2,200 stores in the UK, including pharmacies, health and beauty stores, according to the chain’s website.

Deliberations were ongoing and there was no certainty Reliance, one of the world’s largest multinational conglomerates and India’s largest private sector company, would actually bid for Boots, the Bloomberg report quoted people who asked not to be identified as the information was confidential.

While a spokesperson for Boots declined to comment on the news, Reliance was not available for response either.

The Mumbai-headquartered Reliance Industries — which has already acquired NetMeds, an online medicine seller — has grown on the back of its oil and petrochemicals business. In recent years it has expanded into other sectors including retail, entertainment and telecoms.

Boots UK will be a major global investment attempt by Reliance after its unsuccessful foray into the US shale gas market.

Meanwhile, US-based Walgreens said in January it was conducting a strategic review of the Boots business as the second largest US pharmacy chain renews its focus on domestic healthcare.

A news report earlier in the month indicated that WBA could risk losing billions after a private equity firm interested in buying Boots UK valued the retailer at a steep discount.

In addition to a consortium of CVC Capital Partners and Bain Capital, other suitors for Boots include TDR Capital, which owns supermarket chain Asda, US investment firm Apollo Global Management and Sycamore Capital.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

RPS proposes transition to Royal College, seeks feedback from pharmacy community

The proposed changes will need approval from RPS members through a vote, which is anticipated in early 2025 The...

COVID-19 Inquiry: RPS calls for greater recognition and support for pharmacists

Despite their crucial role during the pandemic, community pharmacy was often an afterthought in government planning, guidance and...

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

CPTPP membership could attract more suppliers to the UK market, thereby reduce drug shortage risks and lower prices...

Community pharmacy ‘overlooked’ during pandemic, NPA tells Covid-19 Inquiry

The NPA asked the Inquiry to consider the resilience of community pharmacy in responding to a future pandemic At...